On the recordDecember 8, 2015
the public health justification for the expedited review, it is off-patent so we know what it is in it, so you do not need the full review that you would need for a first-time drug.
Source
congress.govEditor's note · Context
Senator Kaine discusses the need for expedited reviews for off-patent drugs.
Share
More from Tim Kaine
Aug 15, 2026
We’re thrilled that the Bipartisan Infrastructure Law continues to deliver major investments to Virginia, improving our transportation infrastructure, boosting our Commonwealth’s economy, and creating good-paying jobs.
Aug 23, 2026
I’ll keep working to protect our roadless areas, which support outdoor recreation, tourism, and local economic growth in communities across the country.
Aug 23, 2026
I strongly oppose the Trump-Vance Administration’s rollback of this rule, which would open the door to more development and increased logging in our national forests.
Aug 28, 2026
The violence committed by Israeli settlers in the West Bank is reaching an unprecedented level, and as a result more and more Americans and Palestinians are being killed and injured. These actions – and the Israeli government’s lack of…
Other voices in this conversation
